Engineered “mini livers” could be injected as an alternative to transplantation
MIT researchers have developed a technique to inject engineered 'mini livers' into the body to assist patients with chronic liver disease. These hydrogel-based grafts help hepatocytes remain viable and functional, potentially serving as a bridge to transplantation or an alternative to surgery.
Why it matters
This innovation could significantly improve outcomes for thousands of patients waiting for organ transplants by providing temporary or long-term liver function support.
The tissue grafts could take over the organ’s functions for months, helping thousands of people with liver failure.
The article reports on scientific research in a factual, objective manner without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in